Hai-Yan Zhou1, Wen-Dong Chen, Ding-Liang Zhu, Ling-Yun Wu, Jia Zhang, Wei-Qing Han, Jian-Dong Li, Chen Yan, Ping-Jin Gao. 1. Shanghai Key Laboratory of Vascular Biology, Ruijin Hospital, and Laboratory of Vascular Biology, Health Science Center, Shanghai JiaoTong University School of Medicine and Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, Shanghai, China.
Abstract
BACKGROUND: Increasing evidence has suggested that differentiation of adventitial fibroblasts (AFs) to myofibroblasts plays an important role in arterial remodeling. The molecular mechanisms by which myofibroblast formation is regulated still remain largely unknown. This study aimed to evaluate the role of cyclic nucleotide phosphodiesterase 1A (PDE1A) in the formation of adventitial myofibroblasts induced by transforming growth factor (TGF)-beta(1). METHODS AND RESULTS: AFs were cultured by the explant method. Western blot and immunocytochemistry were applied for alpha-smooth muscle actin (SMA) or protein kinase C (PKC) alpha protein analysis. Results showed that TGF-beta(1) upregulated PDE1A protein expression in rat aortic AFs and pharmacological inhibition of PDE1A blocked TGF-beta(1)-induced alpha-SMA expression, a marker of myofibroblast formation, suggesting that the upregulation of PDE1A may mediate TGF-beta(1)-induced AF transformation. Moreover, calphostin C (a PKC inhibitor) inhibited TGF-beta(1)-induced alpha-SMA expression, whereas phorbol-12-myristate-13-acetate (a PKC activator) induced it. Finally, the upregulation of PKCalpha expression by TGF-beta(1) was also inhibited by PDE1A inhibition. CONCLUSIONS: Taken together, our data suggest that TGFbeta(1) induces alpha-SMA expression and myofibroblast formation via a PDE1A-PKCalpha-dependent mechanism. Our study thus unveils a novel signaling mechanism underlying TGF-beta(1)-induced adventitial myofibroblast formation. Copyright 2009 S. Karger AG, Basel.
BACKGROUND: Increasing evidence has suggested that differentiation of adventitial fibroblasts (AFs) to myofibroblasts plays an important role in arterial remodeling. The molecular mechanisms by which myofibroblast formation is regulated still remain largely unknown. This study aimed to evaluate the role of cyclic nucleotide phosphodiesterase 1A (PDE1A) in the formation of adventitial myofibroblasts induced by transforming growth factor (TGF)-beta(1). METHODS AND RESULTS: AFs were cultured by the explant method. Western blot and immunocytochemistry were applied for alpha-smooth muscle actin (SMA) or protein kinase C (PKC) alpha protein analysis. Results showed that TGF-beta(1) upregulated PDE1A protein expression in rat aortic AFs and pharmacological inhibition of PDE1A blocked TGF-beta(1)-induced alpha-SMA expression, a marker of myofibroblast formation, suggesting that the upregulation of PDE1A may mediate TGF-beta(1)-induced AF transformation. Moreover, calphostin C (a PKC inhibitor) inhibited TGF-beta(1)-induced alpha-SMA expression, whereas phorbol-12-myristate-13-acetate (a PKC activator) induced it. Finally, the upregulation of PKCalpha expression by TGF-beta(1) was also inhibited by PDE1A inhibition. CONCLUSIONS: Taken together, our data suggest that TGFbeta(1) induces alpha-SMA expression and myofibroblast formation via a PDE1A-PKCalpha-dependent mechanism. Our study thus unveils a novel signaling mechanism underlying TGF-beta(1)-induced adventitial myofibroblast formation. Copyright 2009 S. Karger AG, Basel.
Authors: John Wharton; Julian W Strange; Gigi M O Møller; Ellena J Growcott; Xiaohui Ren; Angela P Franklyn; Stephen C Phillips; Martin R Wilkins Journal: Am J Respir Crit Care Med Date: 2005-04-07 Impact factor: 21.405
Authors: Jennifer E Naugle; Erik R Olson; Xiaojin Zhang; Sharon E Mase; Charles F Pilati; Michael B Maron; Hans G Folkesson; Walter I Horne; Kathleen J Doane; J Gary Meszaros Journal: Am J Physiol Heart Circ Physiol Date: 2005-09-02 Impact factor: 4.733
Authors: Oleg V Evgenov; Cornelius J Busch; Natalia V Evgenov; Rong Liu; Bodil Petersen; George E Falkowski; Beata Petho; Adám Vas; Kenneth D Bloch; Warren M Zapol; Fumito Ichinose Journal: Am J Physiol Lung Cell Mol Physiol Date: 2005-11-11 Impact factor: 5.464
Authors: Heather A Burgess; Louis Eugene Daugherty; Thomas H Thatcher; Heather F Lakatos; Denise M Ray; Michelle Redonnet; Richard P Phipps; Patricia J Sime Journal: Am J Physiol Lung Cell Mol Physiol Date: 2005-02-25 Impact factor: 5.464
Authors: Marta Saura; Carlos Zaragoza; Beatrice Herranz; Mercedes Griera; Luisa Diez-Marqués; Diego Rodriguez-Puyol; Manuel Rodriguez-Puyol Journal: Circ Res Date: 2005-10-20 Impact factor: 17.367
Authors: David J Nagel; Toru Aizawa; Kye-Im Jeon; Weimin Liu; Amy Mohan; Heng Wei; Joseph M Miano; Vincent A Florio; Pingjin Gao; Vyacheslav A Korshunov; Bradford C Berk; Chen Yan Journal: Circ Res Date: 2006-03-02 Impact factor: 17.367
Authors: Isola A M Brown; Lukas Diederich; Miranda E Good; Leon J DeLalio; Sara A Murphy; Miriam M Cortese-Krott; Jennifer L Hall; Thu H Le; Brant E Isakson Journal: Arterioscler Thromb Vasc Biol Date: 2018-09 Impact factor: 8.311
Authors: Raffay S Khan; Aalap Chokshi; Konstantinos Drosatos; Hongfeng Jiang; Shuiqing Yu; Collette R Harris; P Christian Schulze; Shunichi Homma; William S Blaner; Gerald I Shulman; Li-Shin Huang; Ira J Goldberg Journal: J Cardiovasc Pharmacol Date: 2013-04 Impact factor: 3.105
Authors: Sanda Alexandrescu; Nina Tatevian; Bogdan A Czerniak; Michael H Covinsky; Nadja K Burns; Robert E Brown Journal: Int J Clin Exp Pathol Date: 2012-07-29